ReoPro (abciximab) is a blood thinner used to prevent blood clots during procedures used to open up the blood vessels in the heart (e.g., balloon angioplasty, coronary stent placement, percutaneous coronary intervention-PCI). ReoPro is usually used with heparin and aspirin.
Abecma (idecabtagene vicleucel) is a B-cell maturation antigen (BCMA)-directed genetically modified autologous T cell immunotherapy used to treat adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody.
Abelcet (amphotericin B lipid complex) Injection is an antifungal antibiotic used to treat a variety of serious fungal infections. Abelcet is available in generic form.
Verzenio (abemaciclib) is a kinase inhibitor indicated in combination with fulvestrant for the treatment of women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer with disease progression following endocrine therapy; and as monotherapy for the treatment of adult patients with HR-positive, HER2-negative advanced or metastatic breast cancer with disease progression following endocrine therapy and prior chemotherapy in the metastatic setting.
Abilify (aripiprazole) is a psychotropic drug (antipsychotic) that alters brain chemical activity used to treat:
Abilify Asimtufii (aripiprazole) is an atypical antipsychotic indicated for the treatment of schizophrenia in adults and as maintenance monotherapy treatment of bipolar I disorder in adults.
Abilify Maintena (aripiprazole) is an antipsychotic drug used for the treatment of schizophrenia.
Abilify MyCite (aripiprazole tablets with sensor) a drug-device combination product comprised of aripiprazole tablets embedded with an Ingestible Event Marker (IEM) sensor intended to track drug ingestion, is indicated for the treatment of adults with schizophrenia; treatment of bipolar I disorder: acute treatment of adults with manic and mixed episodes as monotherapy and as adjunct to lithium or valproate and maintenance treatment of adults as monotherapy and as adjunct to lithium or valproate; and as adjunctive treatment of adults with major depressive disorder (MDD).
Zytiga (abiraterone acetate) is is an inhibitor of CYP17 (17a-hydroxylase/C17,20-lyase) given in combination with prednisone and indicated for the treatment of patients with metastatic castration-resistant prostate cancer.
Yonsa (abiraterone acetate) is a CYP17 inhibitor indicated in combination with methylprednisolone for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC).